10 Genentech finance leaders
Finance Senior Director - Commercial Finance, Head of Finance Global Pharma Technical Development and Finance Director in Tech Ops Finance are among the current titles of these Genentech finance leaders. A reader can learn how finance leaders work at Genentech from people who have held the role.
Professionals to explore
Eduardo Giovaninni Roberto
LinkedInExperience: Sr Director, R&D End-to-End Therapeutic Area Finance Lead - Heme Onc · Genentech
Eduardo Giovaninni Roberto has been Sr Director, R&D End-to-End Therapeutic Area Finance Lead - Heme Onc at Genentech since May 2026 and was Finance Director, R&D Finance Enterprise Partner there from 2022 to 2026. Eduardo Giovaninni Roberto was Sr. Finance Project Manager at Genentech in 2021 and Sr. Finance Manager - Head of Transactional Finance there from 2019 to 2021.
Eduardo Montes
LinkedInExperience: Finance Senior Director - Commercial Finance · Genentech
Eduardo Montes has been Finance Senior Director - Commercial Finance at Genentech since October 2020 and was Finance Director, Personalized Healthcare Finance there from 2019 to 2020. Eduardo Montes was Senior Finance Manager, R&D Finance at Genentech from 2016 to 2018, Senior Finance Manager, G&A Finance there from 2013 to 2016 and Finance Manager at Gap Inc. from 2010 to 2013.
Eric Sass
LinkedInExperience: Finance Director · Genentech
Eric Sass has been Finance Director at Genentech since January 2022, a role the profile describes as Director, Capital and Fixed Assets Finance, and was Principal Finance Manager there from 2015 to 2022. Eric Sass was a Managing Consultant at Capgemini Consulting from 2005 to 2015, a Product Manager at Measurement Specialties from 2001 to 2003 and a Field Artillery Officer in the US Army from 1996 to 2001.
Grace Gu
LinkedInExperience: Finance Director: R&D IBD Portfolio & Afimkibart Global Asset Strategy Lead · Genentech (A Member of the Roche Group)
Grace Gu has been Finance Director: R&D IBD Portfolio & Afimkibart Global Asset Strategy Lead at Genentech (A Member of the Roche Group) since October 2024, based in the San Francisco Bay Area. The profile headline describes Grace Gu as a global pharma finance leader focused on patients and products, and the Genentech role is the only one shown in the listing.
Marion Braegger
LinkedInExperience: Functional Finance Head, Global Product Development · Genentech
Marion Braegger has been Functional Finance Head, Global Product Development at Genentech since May 2025 and has held the role of Senior Director Finance there since September 2023. Marion Braegger was Finance Director at Roche from 2020 to 2023, Head of Functional Finance, Genentech Research and Early Development at Genentech from 2016 to 2020 and Audit Manager at Roche from 2008 to 2011.
Marlene Dong
LinkedInExperience: Director of Finance, R&D Operations · Genentech
Marlene Dong has been Director of Finance, R&D Operations at Genentech since June 2018. Marlene Dong was Senior Finance Manager, Global Operations at Illumina from 2012 to 2018 and Finance Manager, R&D Finance at Amgen from 2008 to 2012, and describes supporting R&D and global operations budgets in FP&A, strategic finance and operations roles.
Moritz Liebert
LinkedInExperience: Head of Finance Global Pharma Technical Development · Genentech
Moritz Liebert has been Head of Finance Global Pharma Technical Development at Genentech since January 2026, a role the profile places in South San Francisco. Moritz Liebert was Finance Enterprise Partner at Roche from 2024 to 2026, Head of Finance - Drug Substance Manufacturing at Roche from 2020 to 2024 and Head of Business Management at Heraeus from 2018 to 2020.
Peach Guan
LinkedInExperience: Finance Director in Tech Ops Finance · Genentech
Peach Guan has been Finance Director in Tech Ops Finance at Genentech since April 2025 and was Senior Finance Manager in R&D Finance there from 2020 to 2025. Peach Guan was an Associate for the Finance Rotational Development Program at Genentech from 2017 to 2020 and a Demand Planner at Maxim Integrated from 2013 to 2015.
Simona Langmaier Boehm
LinkedInExperience: Finance Director, Global Oncology Strategic Finance (R&D and Global Commercial Finance) · Genentech
Simona Langmaier Boehm has been Finance Director, Global Oncology Strategic Finance (R&D and Global Commercial Finance) at Genentech since January 2022 and was Finance Director, Finance Strategy and Operations there from 2018 to 2021. Simona Langmaier Boehm was Head Respiratory Franchise Finance at Genentech from 2015 to 2018 and Senior Finance Manager, Global Supply Chain Finance - Biologics there from 2012 to 2015.
Steve Atkins
LinkedInExperience: Head of Finance for Immunology, Infectious Disease and Ophthalmology, Product Development · Genentech
Steve Atkins has been Head of Finance for Immunology, Infectious Disease and Ophthalmology, Product Development at Genentech since March 2019 and was Lifecycle Controller there from 2016 to 2019. Steve Atkins was a Senior Manager at Monitor Deloitte from 2014 to 2016 and Assistant Vice President, Smart Grids at ABB from 2011 to 2014.
Choose the right perspective
Pick the person whose finance remit is closest to your question, since commercial finance, R&D portfolio finance, technical development and capital finance involve different decisions. Check the start date of each role to see how recent the experience is.
Questions to take into the conversation
- 01What did you look at first when you took on your current finance role, and what did you learn from it?
- 02How do you plan and track spending on a research or development portfolio whose priorities change?
- 03What has your own work taught you about partnering with scientific or commercial leaders on budgets?
Reaching Genentech finance leaders
How can I contact one of these Genentech finance leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 2 companies: Genentech and Genentech (A Member of the Roche Group), based on profile data retrieved on October 19, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Genentech finance leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Genentech finance leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal